Cel-Sci Corporation
Symbol: CVM (NYSE)
8.91
▲ (4.70%) 0.400
Company Description:
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
Key Stats
- Today's Open: $8.58
- Today's High: $9.065
- Today's Low: $8.535
- Today's Volume: 53.03K
- Yesterday Close: $8.51
- Yesterday High: $8.9513
- Yesterday Low: $8.44
- Yesterday Volume: 77.00K
- Last Min Volume: 5
- Last Min High: $8.91
- Last Min Low: $8.91
- Last Min VWAP: $8.91
Company Profile
- Name: Cel-Sci Corporation
- Website: https://www.cel-sci.com
- Listed Date: 1983-12-08
- Location: VIENNA, VA
- Market Status: Active
- CIK Number: 0000725363
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $61.60M
- Round Lot: 100
- Outstanding Shares: 6.88M
- Asset Type: CS
RECENT FILINGS FOR CVM
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-29 | S-8 | View |
| 2025-08-29 | 8-K | View |
| 2025-08-29 | SCHEDULE 13G | View |
| 2025-08-28 | 424B5 | View |
| 2025-08-27 | 424B5 | View |
| 2025-08-25 | 8-K | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-12 | EFFECT | View |
| 2025-08-05 | S-3/A | View |
| 2025-07-29 | 4 | View |
| 2025-07-29 | 4 | View |
| 2025-07-29 | 4 | View |
| 2025-07-29 | 4 | View |
| 2025-07-29 | 4 | View |
| 2025-07-29 | 4 | View |
| 2025-07-29 | 4 | View |
| 2025-07-28 | 4 | View |
| 2025-07-14 | 8-K | View |
| 2025-07-14 | 424B5 | View |
| 2025-07-03 | S-3 | View |
Latest News on CVM